In the future, it will be crucial to collaborate with clinical experts to monitor circulating KLK8 levels in patients with diabetes-associated depression and investigate whether KLK8 levels correlate with DNA methylation levels in the KLK8 promoter region and the severity of depression symptomatology in diabetic patients. The gene discussed is KLK8; the disease is diabetes mellitus.